Today: 24 January 2026
Subscribe
Browse Category

NASDAQ:COGT News 14 January 2026

Cogent Biosciences (COGT) stock jumps as FDA filing timeline sharpens — what investors watch next

Cogent Biosciences (COGT) stock jumps as FDA filing timeline sharpens — what investors watch next

New York, Jan 14, 2026, 13:09 EST — Regular session Cogent Biosciences shares rose about 8% on Wednesday, lifting the biotech’s stock toward recent highs as investors focused on a near-term U.S. regulatory checkpoint for its lead drug candidate, bezuclastinib. The stock was up at $38.17, after trading between $35.17 and $38.34. The move matters because Cogent’s story is now…
14 January 2026
·····

Stock Market Today

  • Philip Morris International Shares Show 16% Undervaluation Despite Recent Rally
    January 24, 2026, 1:15 PM EST. Philip Morris International's stock surged 40.7% over the past year, closing recently at $173.02. Despite this strong share price growth, a Discounted Cash Flow (DCF) analysis suggests the shares remain undervalued by 16.2%, with an estimated fair value of $206.50. The company is shifting focus towards smoke-free and reduced-risk products amid evolving tobacco industry regulations. Its Price-to-Earnings (P/E) ratio is also under review as investors gauge earnings relative to price. However, valuation scores show Philip Morris scores only 1 out of 6 for undervaluation, indicating some caution. The stock's appeal lies in its future cash flow potential, despite recent momentum already priced in.
Go toTop